Aspirin tied to lower risk of liver cancer, death from liver disease

11/28/2012 | U.S. News & World Report

An analysis of data about aspirin and nonsteroidal anti-inflammatory drug use by more than 300,000 people appears to indicate that using aspirin was linked to a 41% lower risk of liver cancer and a 45% reduced chance of dying from chronic liver disease. Although nonsteroidal anti-inflammatory drug use was linked to a 26% lower risk of dying from liver disease, it did not curb the likelihood of liver cancer, researchers said. The findings appear in the Journal of the National Cancer Institute.

View Full Article in:

U.S. News & World Report